Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 27 citing articles:

Impact of SARS-CoV-2 spike antibody positivity on infection and hospitalisation rates in immunosuppressed populations during the omicron period: the MELODY study
Lisa Mumford, Rachel Hogg, Adam J. Taylor, et al.
The Lancet (2025) Vol. 405, Iss. 10475, pp. 314-328
Open Access | Times Cited: 1
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign
Marianne Shawe‐Taylor, David Greenwood, Agnieszka Hobbs, et al.
The Lancet (2024) Vol. 403, Iss. 10432, pp. 1133-1136
Open Access | Times Cited: 6
Impacts of COVID-19 on People Living with Disability
Prosper Mandela A Awuni, James Mbinta
(2025), pp. 1-17
Closed Access
Changes in hospital mortality in patients with cancer during the COVID-19 pandemic (ISARIC-CCP-UK): a prospective, multicentre cohort study
Lance Turtle, Sarah Elliot, Thomas M Drake, et al.
The Lancet Oncology (2024) Vol. 25, Iss. 5, pp. 636-648
Open Access | Times Cited: 4
Sleeper frameworks for Pathogen X: surveillance, risk stratification, and the effectiveness and safety of therapeutic interventions
Simon de Lusignan, Ting Shi, Tom Fowler, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. e417-e418
Closed Access | Times Cited: 3
Real-world effectiveness of sotrovimab for the treatment of SARS-CoV-2 infection during Omicron BA.2 subvariant predominance: a systematic literature review
Myriam Drysdale, Daniel C. Gibbons, Moushmi Singh, et al.
Infection (2023) Vol. 52, Iss. 1, pp. 1-17
Open Access | Times Cited: 9
Impact of the SARS-CoV-2 infection in individuals with sickle cell disease: an integrative review
Laura Resende Guimarães Pereira, Maria Vitoria Gomes da Silva, Carla Maria Ramos Germano, et al.
Frontiers in Medicine (2023) Vol. 10
Open Access | Times Cited: 8
COVID-19 vaccine effectiveness against hospitalisation and death of people in clinical risk groups during the Delta variant period: English primary care network cohort study
Heather Whitaker, Ruby S. M. Tsang, Rachel Byford, et al.
Journal of Infection (2023) Vol. 87, Iss. 4, pp. 315-327
Open Access | Times Cited: 8
Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study
Myriam Drysdale, Evgeniy R. Galimov, Marcus J. Yarwood, et al.
BMJ Open Respiratory Research (2024) Vol. 11, Iss. 1, pp. e002238-e002238
Open Access | Times Cited: 2
sTREM-1 as a Predictive Biomarker for Disease Severity and Prognosis in COVID-19 Patients
Nan Geng, Zhipeng Wu, Zhao Liu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 3879-3891
Open Access | Times Cited: 2
Study on the predictive value of laboratory inflammatory markers and blood count-derived inflammatory markers for disease severity and prognosis in COVID-19 patients: a study conducted at a university-affiliated infectious disease hospital
Zhipeng Wu, Yu Cao, Zhao Liu, et al.
Annals of Medicine (2024) Vol. 56, Iss. 1
Open Access | Times Cited: 2
Deviation from the recommended schedule: optimal dosing interval for a two-dose vaccination programme
Zhen Wang, Gergely Röst, Seyed M. Moghadas
Royal Society Open Science (2024) Vol. 11, Iss. 7
Open Access | Times Cited: 1
Adult risk groups for vaccine preventable respiratory infections: an overview of the UK environment
Charles Reynard, James Campling, Adam Gordon, et al.
Expert Review of Vaccines (2024) Vol. 23, Iss. 1, pp. 1052-1067
Open Access | Times Cited: 1
COVID-19 infection, admission and death and the impact of corticosteroids among people with rare autoimmune rheumatic disease during the second wave of COVID-19 in England: results from the RECORDER Project
Megan Rutter, Peter Lanyon, Matthew J. Grainge, et al.
Lara D. Veeken (2023) Vol. 62, Iss. 12, pp. 3828-3837
Open Access | Times Cited: 4
Prediction models of COVID-19 fatality in nine Peruvian provinces: A secondary analysis of the national epidemiological surveillance system
Wendy Nieto‐Gutierrez, Jaid Campos-Chambergo, Enrique Gonzalez-Ayala, et al.
PLOS Global Public Health (2024) Vol. 4, Iss. 1, pp. e0002854-e0002854
Open Access
Association Between Artificial Intelligence Based Chest Computed Tomography and Clinical/Laboratory Characteristics with Severity and Mortality in COVID-19 Hospitalized Patients
Jiawei Ye, Yingying Huang, Caiting Chu, et al.
Journal of Inflammation Research (2024) Vol. Volume 17, pp. 2977-2989
Open Access
Development and validation of a scoring system to predict the mortality of hospitalized patients with SARS-CoV-2 Omicron: a nationwide, multicentre study
Wanru Guo, Xiaomeng Li, Cheng Ding, et al.
BMC Pulmonary Medicine (2024) Vol. 24, Iss. 1
Open Access
Impact of Diabetes Mellitus On In-Hospital Mortality of COVID-19 Patients in Japan Since COVID-19 Became a Common Infectious Disease
Yohei Fujita, Masahiro Hatazaki, Satoshi Fujimi
Cureus (2024)
Open Access
Risk of death in England following a positive SARS-CoV-2 test: A retrospective national cohort study (March 2020 to September 2022)
Clarissa Bauer‐Staeb, Richard Holleyman, Sharmani Barnard, et al.
PLoS ONE (2024) Vol. 19, Iss. 10, pp. e0304110-e0304110
Open Access
Prevention is better than cure: immunocompromised people need COVID-19 prevention therapies now
Antonio Pagliuca, Sundeep Kaul, Carl S. Goodyear, et al.
Infectious Diseases (2024) Vol. 56, Iss. 12, pp. 1107-1110
Open Access
Accuracy of the Canadian COVID-19 Mortality Score (CCMS) to predict in-hospital mortality among vaccinated and unvaccinated patients infected with Omicron: a cohort study
Corinne M. Hohl, David Seonguk Yeom, Justin W. Yan, et al.
BMJ Open (2024) Vol. 14, Iss. 11, pp. e083280-e083280
Open Access
Risk of Severe Outcomes From COVID-19 in Immunocompromised People During the Omicron Era: A Systematic Review and Meta-Analysis
Andrew R. Chapman, Francis Bérenbaum, Giuseppe Curigliano, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Risk of Severe Outcomes From COVID-19 in Comorbid Populations in the Omicron Era: A Meta-analysis
Andrew R. Chapman, Dan H. Barouch, Gregory Y.H. Lip, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals
Christoph D. Spinner, Samira Bell, Hermann Einsele, et al.
Advances in Therapy (2024) Vol. 42, Iss. 2, pp. 666-719
Open Access
Impact of COVID-19 vaccines in patients on hemodialysis: an Italian multicentre cohort study
Salvatore De Masi, Roberto Da, Francesca Menniti‐Ippolito, et al.
Journal of Nephrology (2024) Vol. 37, Iss. 7, pp. 1871-1880
Closed Access
Page 1 - Next Page

Scroll to top